Neuropace Inc. Watch

from 10-Q 7 pages June 5, 2025 1)employment by the Company. A)position. You Will Serve as the Company’s Chief Financial Officer. B)duties. You Will Perform Those Duties and Responsibilities as Are Customary for the Position of Chief Financial Officer and as May Be Directed by the Chief Executive Officer, to Whom You Will Report. D)start Date. if You Find the Terms of This Letter Agreeable, You Will Commence This New Position With the Company on a Mutually Agreed Upon Date No Later Than July 3, 2025 (Your “Start Date”). E)conditions. for Purposes of Federal Immigration Law, You Will Be Required to Provide to the Company Documentary Evidence of Your Identity and Eligibility for Employment in the United States. Such Documentation Must Be Provided Within Three (3) Business Days of Your Start Date. This Offer Is Further Contingent Upon Satisfactory Reference and Background Checks

from 10-Q 8 pages June 20, 2025 Rebecca Kuhn

from 10-Q 10 pages Stock Purchase Agreement

from 10-K 2 pages Neuropace, Inc. Non-Employee Director Compensation Policy Revised and Approved October 30, 2024

from 10-K 5 pages Neuropace, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Grant Notice

from 10-K 4 pages Second Amendment to the Supply Agreement

from 10-K 3 pages First Amendment to the Supply Agreement

from 10-K 24 pages Amended Supply Agreement

from 10-K 9 pages February 1, 2024 Irina Ridley via Email/Docusign Dear Irina: This Letter (The “Agreement”) Sets Forth the Terms of Your Separation and Transition Agreement With Neuropace, Inc. (The “Company”)

from 8-K 33 pages Neuropace, Inc. 2023 Inducement Plan Adopted by the Compensation Committee of the Board of Directors: July 18, 2023

from 8-K 5 pages Joel D. Becker via Email Re: Offer Letter and Employment Agreement Dear Joel

from 8-K 6 pages Neuropace, Inc. Consulting Agreement

from 10-Q 3 pages Amendment 1 to Supply Agreement By: /S/ Juergen Lindner By: /S/ Rebecca Kuhn Juergen Lindner Rebecca Kuhn General Manager Chief Financial Officer & Vice President Finance & Administration 1

from 10-Q 46 pages Exclusive Distribution Agreement

from 10-Q 6 pages 455 North Bernardo Avenue Second Amendment to Office Lease

from S-1/A 20 pages Supply Agreement

from S-1/A 2 pages Amendment One to the Supply Agreement

from S-1/A 34 pages Supply Agreement

from S-1/A 12 pages Indemnity Agreement

from S-1/A 13 pages Neuropace, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: April 7, 2021 Approved by the Stockholders: April 8, 2021